NCT02921997: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 579 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02921997 |
|---|---|
| Title | A Phase II Study to Evaluate and Compare the Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered With and Without AS03 Adjuvant and Monovalent Inactivated Influenza A/H3N2v Virus Vaccine Administered Without Adjuvant in Healthy Adults Through Standard and Systems Biology Analyses |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 7, 2016 |
| Completion date | March 28, 2017 |
| Required reporting date | March 28, 2020, midnight |
| Actual reporting date | Oct. 28, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 579 |